These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8913452)

  • 21. Nephrotoxicity of gentamicin and tobramycin given once daily or continuously in dogs.
    Reiner NE; Bloxham DD; Thompson WL
    J Antimicrob Chemother; 1978 May; 4 Suppl A():85-101. PubMed ID: 659354
    [No Abstract]   [Full Text] [Related]  

  • 22. Glomerular and Tubular Renal Function after Repeated Once-Daily Tobramycin Courses in Cystic Fibrosis Patients.
    Stehling F; Büscher R; Grosse-Onnebrink J; Hoyer PF; Mellies U
    Pulm Med; 2017; 2017():2602653. PubMed ID: 28133546
    [No Abstract]   [Full Text] [Related]  

  • 23. Monitoring of a single post-infusion blood sample to estimate the actual peak and trough concentration of tobramycin in critically ill patients.
    Reimann IR; Meier-Hellmann A; Traut T; Reinhart K; Hoffmann A
    Exp Toxicol Pathol; 2003 Jun; 54(5-6):493-8. PubMed ID: 12877363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Once-daily gentamicin dosing of 4 Mg/Kg/dose in neonates.
    Kiatchoosakun P; Kosalaraksa P; Jirapradittha J; Taksaphan S; Tassniyom S
    J Med Assoc Thai; 2005 Jul; 88(7):934-8. PubMed ID: 16241022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gentamicin and renal function: lessons from 15 years' experience of a pharmacokinetic service for extended interval dosing of gentamicin.
    Plajer SM; Chin PK; Vella-Brincat JW; Buffery PJ; Begg EJ
    Ther Drug Monit; 2015 Feb; 37(1):98-103. PubMed ID: 24943063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin.
    Smith CR; Lipsky JJ; Laskin OL; Hellmann DB; Mellits ED; Longstreth J; Lietman PS
    N Engl J Med; 1980 May; 302(20):1106-9. PubMed ID: 6988713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of once-daily dosing vs. multiple daily dosing of tobramycin on enzyme markers of nephrotoxicity.
    Olsen KM; Rudis MI; Rebuck JA; Hara J; Gelmont D; Mehdian R; Nelson C; Rupp ME
    Crit Care Med; 2004 Aug; 32(8):1678-82. PubMed ID: 15286543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective study evaluating tobramycin pharmacokinetics and optimal once daily dosing in burn patients.
    Lee C; Walker SAN; Walker SE; Seto W; Simor A; Jeschke M
    Burns; 2017 Dec; 43(8):1766-1774. PubMed ID: 28647460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for toxicity in elderly patients given aminoglycosides once daily.
    Paterson DL; Robson JM; Wagener MM
    J Gen Intern Med; 1998 Nov; 13(11):735-9. PubMed ID: 9824518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive performance of gentamicin dosing nomograms.
    Lee J; Yoon S; Shin D; Han H; An H; Lee J; Lim KS; Yu KS; Lee H
    Drug Des Devel Ther; 2014; 8():1097-106. PubMed ID: 25152616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Once versus thrice daily gentamicin in patients with serious infections.
    Prins JM; Büller HR; Kuijper EJ; Tange RA; Speelman P
    Lancet; 1993 Feb; 341(8841):335-9. PubMed ID: 8094114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Once daily aminoglycoside dosing: maintained efficacy with reduced nephrotoxicity?
    Zhanel GG; Ariano RE
    Ren Fail; 1992; 14(1):1-9. PubMed ID: 1561384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical nephrotoxicity of tobramycin and gentamicin. A prospective study.
    Kumin GD
    JAMA; 1980 Oct; 244(16):1808-10. PubMed ID: 7420681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circadian variations in serum levels and the renal toxicity of aminoglycosides in patients.
    Prins JM; Weverling GJ; van Ketel RJ; Speelman P
    Clin Pharmacol Ther; 1997 Jul; 62(1):106-11. PubMed ID: 9246024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Smyth AR; Bhatt J
    Cochrane Database Syst Rev; 2012 Feb; (2):CD002009. PubMed ID: 22336782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Once-daily dosed gentamicin is more nephrotoxic than once-daily dosed tobramycin in clinically infected patients.
    van Maarseveen E; van Buul-Gast MC; Abdoellakhan R; Gelinck L; Neef C; Touw D
    J Antimicrob Chemother; 2014 Sep; 69(9):2581-3. PubMed ID: 24872345
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical assessment of a published model to predict aminoglycoside-induced nephrotoxicity.
    Garrison MW; Rotschafer JC
    Ther Drug Monit; 1989; 11(2):171-5. PubMed ID: 2718222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aminoglycoside pharmacokinetics: dosage requirements and nephrotoxicity in trauma patients.
    Townsend PL; Fink MP; Stein KL; Murphy SG
    Crit Care Med; 1989 Feb; 17(2):154-7. PubMed ID: 2914447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
    Cosgrove SE; Vigliani GA; Fowler VG; Abrutyn E; Corey GR; Levine DP; Rupp ME; Chambers HF; Karchmer AW; Boucher HW
    Clin Infect Dis; 2009 Mar; 48(6):713-21. PubMed ID: 19207079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Easier monitoring of aminoglycoside therapy with once-daily dosing schedules.
    Prins JM; Koopmans RP; Büller HR; Kuijper EJ; Speelman P
    Eur J Clin Microbiol Infect Dis; 1995 Jun; 14(6):531-5. PubMed ID: 7588829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.